NCT01825967

Brief Summary

The management of acute diverticulitis maybe better if we have prognostic markers of evolution. Hypothesis: C-reactive protein maybe a good prognostic marker of evolution of acute diverticulitis. The investigators need to know the values of C-reactive protein to predict evolution of acute diverticulitis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2013

Shorter than P25 for all trials

Geographic Reach
1 country

4 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 29, 2013

Completed
3 days until next milestone

Study Start

First participant enrolled

April 1, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 8, 2013

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2014

Completed
Last Updated

April 10, 2013

Status Verified

April 1, 2013

Enrollment Period

1 year

First QC Date

March 29, 2013

Last Update Submit

April 9, 2013

Conditions

Acute Diverticulitis

Outcome Measures

Primary Outcomes (1)

  • C-Reactive Protein

    24 Hours

Study Arms (1)

Acute Diverticulitis

We measured C-reactive protein in all the patients diagnosed with acute diverticulitis

Other: C-reactive protein

Interventions

C-reactive proteinOTHER

measured C-reactive protein in all patients with acute diverticulitis

Acute Diverticulitis

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All Patients with Acute Diverticulitis

You may qualify if:

  • Acute Diverticulitis

You may not qualify if:

  • Other Abdominal Pathologies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Corporacion Parc Tauli

Sabadell, Barcelona, 08208, Spain

Location

Corporacion parc tauli

Sabadell, Sabadell-Barcelona, 08208, Spain

Location

Corporacion Parc Tauli

Sabadell, Sabadell/barcelona, 08208, Spain

Location

Corporacion Parc Tauli

Sabadell, Sabadell/barcelona, 08208, Spain

Location

MeSH Terms

Interventions

C-Reactive Protein

Intervention Hierarchy (Ancestors)

AlbuminsProteinsAmino Acids, Peptides, and ProteinsAcute-Phase ProteinsBlood ProteinsImmunoproteins

Study Officials

  • MORA LAURA, MD

    Corporacion Parc Tauli

    PRINCIPAL INVESTIGATOR

Central Study Contacts

MORA L. LAURA, MD

CONTACT

34639101033Lmora@tauli.cat

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
30 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
General Surgeon

Study Record Dates

First Submitted

March 29, 2013

First Posted

April 8, 2013

Study Start

April 1, 2013

Primary Completion

April 1, 2014

Study Completion

April 1, 2014

Last Updated

April 10, 2013

Record last verified: 2013-04

Locations

ES(4)